Nanovery raises €2.1M Seed round

6 April 2023· Newcastle upon Tyne, United Kingdom· health, oncology, biotech, ai, b2b, deep_hardware

The funding was raised to further the mission of improving testing for prostate cancer and to make breakthroughs in disease detection and diagnostic technologies.

Investors

LeadNorthstar Ventures

Also participating

Innovate UKProstate Cancer ResearchJR Holding ASI

About Nanovery

Stage

Seed

Headquarters

Newcastle upon Tyne, United Kingdom

Founded

2018

Team Size

6–20

Sectors

healthoncologybiotechaib2bdeep_hardware

https://www.nanovery.co.uk/

Source: https://www.prostate-cancer-research.org.uk/nanovery-secures-over-1-85-million/